NATCO Pharma Limited

P/E Ratio

13.43x

Below 15 = value stock, 15-25 = fairly valued, above 30 = growth premium

Price-to-Book (P/B)

2.39x

Below 1.0 = potentially undervalued, 1-3 = typical, banking sector often 1-2x

Earnings Per Share (EPS)

₹85.92

Higher is better — compare within the same industry for meaningful benchmarks

Return on Equity (ROE)

19.44%

Above 15% is strong, top companies exceed 20%. Below 10% is weak

Debt-to-Equity Ratio

0.03x

Below 0.5 = conservative, 0.5-1.0 = moderate, above 2.0 = high leverage

Beta

0.12

1.0 = moves with market, below 0.8 = defensive, above 1.2 = aggressive

52-Week Range Position

72.60%

0% = at 52-week low, 50% = midpoint, 100% = at 52-week high

Dividend Yield

0.77%

2-4% is typical, above 5% is high yield (verify sustainability), 0% = no dividend

Current Market Price

₹1,153.8

Use this to filter by price range — e.g., penny stocks below ₹50, blue chips above ₹1000

Market Capitalisation

₹2066569.8L Cr

Large-cap > ₹20,000 Cr, Mid-cap ₹5,000-20,000 Cr, Small-cap < ₹5,000 Cr

Fifty Two Week High

1340.45

Fifty Two Week Low

660.05